Valued at USD 11.72 billion in 2025, the blockchain in healthcare market is projected to reach USD 15.67 billion in 2026 and USD 164.89 billion by 2034, growing at a CAGR of 34.15% during the forecast period 2026–2034. Growth reflects rising preference for personalized medicine and genomics, advances in diagnostics, and the need to secure patient data. Major players include Blockpharma, BurstIQ, Change Healthcare (acquired by UnitedHealth Group's Optum), iSolve, LLC, PATIENTORY INC., IBM, and Oracle.

Personalized Medicine and Diagnostics Drive the Blockchain in Healthcare Market

The advancement of personalized medicine and genomics requires secure, effective management of vast volumes of sensitive genetic data. Blockchain securely stores and shares genetic information, protecting patient privacy while giving researchers and providers the data needed for treatment plans. In May 2024, OM1 announced three new products, OM1 Lyra, OM1 Orion, and OM1 Polaris, powered by the PhenOM AI digital phenotyping platform to expedite the delivery of personalized medicine.

Advances in healthcare diagnostics are also lifting adoption, improving the precision, speed, and accessibility of services and enabling earlier, more accurate diagnoses. The growing integration of AI and blockchain is fueling progress, and ZayaAI partnered with Enjinstarter, a Web3 Launchpad and advisory firm, to harness both technologies for better diagnostics and outcomes.

Browse Full Insights:

https://www.polarismarketresearch.com/industry-analysis/blockchain-in-healthcare

Data Breaches and Secure Exchange Opportunities

The growing incidence of data breaches in the healthcare industry is expected to offer opportunities during the forecast period. Blockchain's decentralized and encrypted nature provides high levels of security and privacy, making it attractive to healthcare organizations, while AI detects ransomware threats, phishing attempts, and unauthorized access faster than traditional systems. AI also analyzes vast medical datasets to forecast diseases and personalize treatments, and blockchain ensures the integrity of those datasets, making AI-driven insights more reliable. The rise of telemedicine and remote patient monitoring further necessitates robust platforms for managing and exchanging patient data securely, and blockchain offers potential for secure data exchange between patients and providers. Governments and regulatory bodies worldwide are promoting adoption through favorable regulatory frameworks, financial support, and pilot initiatives.

End-Use Outlook for Biopharmaceutical and Device Firms

By end use, the market covers healthcare providers, healthcare payers, biopharmaceutical & medical device companies, and others. The biopharmaceutical & medical device companies segment is expected to witness the fastest growth from 2026 to 2034, owing to a surge in surgical and medical instrument manufacturing.

According to the US Department of Commerce, surgical and medical instrument manufacturing generated the highest sales in the medical devices industry in 2020, at approximately USD 36.3 billion, while pharmaceutical preparation manufacturing led the biopharmaceutical industry with approximately USD 154.7 billion in revenue. This expansion creates a need for secure and transparent supply chains, and blockchain ensures the traceability and authenticity of medical devices throughout their lifecycle.

Regional Opportunities and Industry Developments

Asia Pacific is expected to grow at the fastest CAGR, supported by investments in healthcare infrastructure and technology and rapid digital transformation of the sector. North America accounted for the largest share in 2025, aided by regulatory support and favorable government initiatives, with the US holding the largest national share. China is expected to grow significantly as telemedicine and digital health services highlight the need for secure, interoperable platforms that protect patient data and facilitate seamless care delivery.

In December 2024, Microsoft Azure rolled out Health Data Consortium capabilities enabling multi-jurisdictional blockchain data sharing with robust, patient-centric privacy controls. In April 2023, HealthSync leveraged the Oracle Blockchain in Healthcare Platform to consolidate data into a decentralized ledger, giving providers accurate, real-time information. Market participants are expanding their global footprint through new product launches, contractual agreements, mergers and acquisitions, higher investments, and collaborations, while cost-effective offerings are needed to compete. High implementation costs remain a restraint on market expansion.

More Trending Latest Reports By Polaris Market Research:

Gynecological Examination Chairs Market

Fluoropolymers Market

Safari Tourism Market

Enterprise Content Management Market

Automotive Ceramics Market

Mass Flow Controller Market

Hemophilia A Treatment Market

AI Trust, Risk and Security Management Market